Hydromer Announces Strategic Investment by JMEDTECH and Board Restructuring
Hydromer's partnership with JMEDTECH creates a global medical device coating platform that enhances supply chain resilience and expands technological capabilities across major markets.
Hydromer, Inc., a leader in hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices, has announced a strategic investment from JMEDTECH alongside the formation of a new Board of Directors. This partnership establishes a future-oriented global medical device coating platform that integrates UV-curable and thermal-cure coating systems supported by advanced coating equipment and regionalized services.
The collaboration represents a significant milestone for both companies, amplifying Hydromer's technological and brand influence while marking a critical step in JMEDTECH's global expansion strategy. By uniting capabilities across Asia and the Americas, the companies are establishing a mirror-delivery network covering major medical device markets worldwide. This strategic move significantly enhances supply chain resilience and responsiveness, creating greater value for customers through comprehensive solutions spanning research and development, validation, and mass production.
Michael Torti will continue to serve as CEO and Director, working with Chairman Jacqueline Zhang and the refreshed Board to provide strong leadership and industry expertise as Hydromer enters its next phase of growth. The company expressed gratitude to departing directors Braeden Lichti and George Kovalyov for their leadership and contributions during their tenure with the organization.
"Our company couldn't be more pleased to join forces with JMEDTECH and its fine leaders," said Michael Torti, CEO of Hydromer. "For over 40 years, Hydromer has been an innovator in the surface conversion coatings industry and now, with the support of one of the most innovative companies in our industry, together we will bring perhaps the broadest range of coating capabilities, including automatic large-scale coating systems, to the Global Medical Device marketplace."
The partnership enables Hydromer to leverage JMEDTECH's resources and expertise while maintaining its position as a dominant player in medical device coating technologies. The combined platform offers customers worldwide access to sophisticated coating solutions backed by decades of industry experience and technological innovation. This strategic alignment comes at a time when global medical device manufacturers increasingly seek reliable, scalable coating solutions that can meet rigorous regulatory standards across multiple geographic regions.
The enhanced global footprint and technological capabilities position the combined entity to better serve the evolving needs of medical device manufacturers facing complex supply chain challenges and increasing regulatory requirements. The mirror-delivery network concept represents an innovative approach to ensuring consistent product quality and availability across different markets while reducing dependency on single-source manufacturing locations.